Ontology highlight
ABSTRACT: Rationale
Atomoxetine is a noradrenaline re-uptake inhibitor licensed for the treatment of adult and childhood attention deficit hyperactivity disorder. Although atomoxetine has established efficacy, the mechanisms which mediate its effects are not well understood.Objectives
In this study, we investigated the role of cortical versus sub-cortical noradrenaline by using focal dopamine beta hydroxylase-saporin-induced lesions, to the prefrontal cortex (n = 16) or nucleus accumbens shell (n = 18).Methods
Healthy animals were tested by using the forced-choice serial reaction time task to assess the impact of the lesion on baseline performance and the response to atomoxetine and the psychostimulant amphetamine.Results
We observed attenuation in the efficacy of ato
SUBMITTER: Benn A
PROVIDER: S-EPMC5203835 | biostudies-literature | 2017 Jan
REPOSITORIES: biostudies-literature